World's Best Scientists 2026 revealed!
Yusuke Oji

Yusuke Oji

D-Index & Metrics

Immunology

D-Index
53
Citations
11556
World Ranking
3965
National Ranking
155

Yusuke Oji publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yusuke Oji sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 182 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yusuke Oji D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yusuke Oji sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yusuke Oji is affiliated with Osaka University in Japan and has contributed extensively to the fields of medicine, immunology and microbiology, and biochemistry, genetics and molecular biology. Their research primarily spans immunology, molecular biology, and oncology, with additional work in radiology, nuclear medicine and imaging, and genetics.

The main research topics addressed by Yusuke Oji include renal and related cancers, immunotherapy and immune responses, CAR-T cell therapy research, cancer immunotherapy and biomarkers, immune cell function and interaction, epigenetics and DNA methylation, and T-cell and B-cell immunology.

Frequent publication venues for Yusuke Oji include:

  • Cancer Immunology Immunotherapy
  • Journal of Hematology & Oncology
  • Neuro-Oncology Advances
  • Science Translational Medicine
  • Journal of Immunotherapy

Yusuke Oji has collaborated extensively with several researchers, including:

  • Haruo Sugiyama
  • Yoshitaka Oka
  • Akihiro Tsuboi
  • Soyoko Morimoto
  • Hiroko Nakajima

Selected recent papers authored or co-authored by Yusuke Oji are:

  • Selective targeting of multiple myeloma cells with a monoclonal antibody recognizing the ubiquitous protein CD98 heavy chain, 2022, Science Translational Medicine
  • Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer, 2021, Journal of Immunotherapy
  • Imaging Assessment of Tumor Response in the Era of Immunotherapy, 2021, Diagnostics
  • Reader-free ELISPOT assay for immuno-monitoring in peptide-based cancer vaccine immunotherapy, 2020, Biomedical Reports
  • Maintenance of WT1 expression in tumor cells is associated with a good prognosis in malignant glioma patients treated with WT1 peptide vaccine immunotherapy, 2021, Cancer Immunology Immunotherapy

Best Publications

  • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression

    Yoshihiro Oka;Akihiro Tsuboi;Tetsuya Taguchi;Tadashi Osaki

  • CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

    Naoki Hosen;Christopher Y. Park;Naoya Tatsumi;Yusuke Oji

  • Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

    Kazushi Inoue;Hiroyasu Ogawa;Hiroyasu Ogawa;Yoshiaki Sonoda;Yoshiaki Sonoda;Takafumi Kimura;Takafumi Kimura

  • Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

    Viggo F. van Tendeloo;Ann Van de Velde;Ann van Driessche;Nathalie Cools

  • Human cytotoxic T-lymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1 ) product.

    Yoshihiro Oka;Olga A. Elisseeva;Akihiro Tsuboi;Hiroyasu Ogawa

  • Immunohistochemical detection of WT1 protein in a variety of cancer cells

    Shin-ichi Nakatsuka;Yusuke Oji;Tetsuya Horiuchi;Takayoshi Kanda

  • The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia.

    Hiroyasu Ogawa;Hiroya Tamaki;Kazuhiro Ikegame;Toshihiro Soma

  • Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers

    Yusuke Oji;Shinichiro Miyoshi;Hajime Maeda;Seiji Hayashi

  • Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels

    Kazushi Inoue;Hiroyasu Ogawa;Tamotsu Yamagami;Toshihiro Soma

  • Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells

    Kazushi Inoue;Hiroya Tamaki;Hiroyasu Ogawa;Yoshihiro Oka

  • The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes.

    H. Tamaki;H. Ogawa;K. Ohyashiki;Jh H. Ohyashiki

  • Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

    Sébastien Anguille;Ann L. Van De Velde;Evelien L. Smits;Viggo F. Van Tendeloo

  • Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies.

    Olga A. Elisseeva;Yoshihiro Oka;Akihiro Tsuboi;Kiyoyuki Ogata

  • Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.

    Yusuke Oji;Shoji Nakamori;Masahiro Fujikawa;Shin-ichi Nakatsuka

  • Very low frequencies of human normal CD34+ haematopoietic progenitor cells express the Wilms' tumour gene WT1 at levels similar to those in leukaemia cells

    Naoki Hosen;Yoshiaki Sonoda;Yusuke Oji;Takafumi Kimura

  • Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors

    Yusuke Oji;Tsuyoshi Suzuki;Yoko Nakano;Motohiko Maruno

  • The activated conformation of integrin β 7 is a novel multiple myeloma–specific target for CAR T cell therapy

    Naoki Hosen;Yukiko Matsunaga;Kana Hasegawa;Hiroshi Matsuno

  • Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues.

    Akihiro Tsuboi;Yoshihiro Oka;Keiko Udaka;Masaki Murakami

  • Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma

    Yusuke Oji;Hirofumi Yamamoto;Masaya Nomura;Yoko Nakano

  • AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.

    Sumiyuki Nishida;Naoki Hosen;Toshiaki Shirakata;Keisuke Kanato

  • Wilms tumor gene peptide-based immunotherapy for patients with overt leukemia from myelodysplastic syndrome (MDS) or MDS with myelofibrosis.

    Yoshihiro Oka;Akihiro Tsuboi;Masaki Murakami;Manabu Hirai

Frequent Co-Authors

Haruo Sugiyama
Haruo Sugiyama Osaka University
Yoshihiro Oka
Yoshihiro Oka Osaka University
Atsushi Kumanogoh
Atsushi Kumanogoh Osaka University
Katsuyuki Aozasa
Katsuyuki Aozasa Osaka University
Tadamitsu Kishimoto
Tadamitsu Kishimoto Osaka University
Satoshi Morita
Satoshi Morita Kyoto University
Eiichi Morii
Eiichi Morii Osaka University
Masaki Yasukawa
Masaki Yasukawa Ehime University
Zwi N. Berneman
Zwi N. Berneman University of Antwerp
Hideki Yoshikawa
Hideki Yoshikawa Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare education pathways can offer diverse opportunities. Many students transition into roles that bridge clinical care and research, where understanding the immune system is crucial.

One popular option is an accelerated nurse practitioner program, which fast-tracks students into advanced nursing roles. These programs emphasize both clinical skills and scientific knowledge, complementing immunology expertise.

If you are coming from a non-nursing background, enrolling in the best online BSN programs for non nurses can provide foundational nursing knowledge alongside flexible learning formats suited to busy schedules.

When looking for accessible entry points into nursing, options such as the easiest ABSN programs to get into or accredited LPN programs easy to get into may serve as practical pathways. These programs prioritize inclusivity and often feature streamlined admissions processes.

Combining immunology studies with nursing credentials can open doors in clinical research, healthcare delivery, and public health, making these related degrees valuable complements to an immunology career.

Best Scientists Citing Yusuke Oji

Trending Scientists

Recently Published Articles